Waleed H Hassanein sold $1.2M of TransMedics (TMDX)

Executed Sep 16 2024, disclosed Sep 17 2024, 1 day later.

Value, as filed

$1.2M

7,999 sh across 5 lots

Executed

Sep 16 2024

the trade date, as filed

Disclosed

Sep 17 2024

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

WH Waleed H Hassanein President & CEO profile →

Waleed H Hassanein (President & CEO) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in TransMedics Group, Inc. (TMDX). Across 1 priced purchase filing, the average 21-session return was +9.2% from execution and +9.0% from disclosure (delay-adjusted; derived). The largest single filing was $1.0M of TMDX (8,775 sh × $114.00, as filed), executed Nov 17 2025.

The name

TMDX TransMedics Group, Inc. TMDX · Healthcare · 21 filings in 24 months ticker →

Healthcare · TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage orga…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Waleed H Hassanein in TMDX

TMDXPURCHASE TransMedics Group, Inc. $1.0M
8,775 sh × $114.00
Exec Nov 17 2025
Filed Nov 18 2025 · 4:30 PM ET TMDXPURCHASE TransMedics Group, Inc. $2.0M
16,875 sh across 3 lots
Exec Aug 6 2025
Filed Aug 8 2025 · 4:30 PM ET TMDXSALE TransMedics Group, Inc. $1.1M
8,325 sh across 3 lots
Exec Oct 15 2024
Filed Oct 17 2024 · 5:30 PM ET